Innovation: why companies are choosing higher speed, higher risk collaborations for R&D

In the recent ‘2012 EU Survey on R&D Investment Business Trends’ an intriguing statement is made about R&D in sectors like biopharma, ICT and high- tech. It says ‘Collaboration agreements were a more important way of knowledge sharing than licencing. For companies in high R&D intensity sectors, this is followed by licencing in/out with other companies, and then collaboration agreements with higher ...